Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 |
filingDate |
2014-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2017-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58c12f40e3e0c9c09fcf7763045e253a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b56750e51b4f8095df44fbcf3f40c9d1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_099b291f596bf82a8ccbe052f2e88aa3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8aaa91d671e6e7adf17961d2130e636e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8324342d2eb7b06e1f189435796db294 |
publicationDate |
2017-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2642201-T3 |
titleOfInvention |
Quinazoline inhibitors of mutant forms of epidermal growth factor receptor activation |
priorityDate |
2013-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |